てんかん発作治療の世界市場レポート 2025年

てんかん発作治療市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR6.6％で47億2,000万米ドルに成長します。予測期間の成長は、精密医療アプローチ、新たな治療様式、遠隔医療と遠隔モニタリング、ヘルスケア統合と集学的ケア、規制支援とインセンティブに起因します。予測期間中の主な動向には、個別化医療、デジタルヘルスソリューションの統合、新たな治療法、併存疾患とQOLの重視、規制支援と市場参入などがあります。

てんかん罹患率の増加は、てんかん発作治療市場の今後の成長を促進すると予測されます。てんかんは、再発性の非誘発性発作を特徴とする神経疾患で、脳内の異常な電気的活動に起因し、けいれん、意識消失、感覚障害や行動障害などのさまざまな症状を引き起こします。てんかんの有病率上昇の要因としては、脳損傷や脳卒中患者の生存率の向上、高齢者人口の増加などが挙げられます。抗てんかん薬（AED）を中心としたてんかん発作の効果的な治療により、発作の頻度や重症度が大幅に低下するため、患者の日常生活機能や全体的な幸福が確保されます。例えば、2024年2月現在、世界保健機関（WHO）によると、てんかん患者数は全世界で約5,000万人、毎年約500万人が新たにてんかんと診断されています。したがって、てんかんの発生率の増加が、てんかん発作の治療市場の拡大に拍車をかけています。

てんかん発作治療市場の主なプレーヤーは、特に従来の抗てんかん薬に反応しない患者のために、大麻ベースの薬などの代替治療ソリューションを開拓するために技術革新を進めています。大麻植物に由来する大麻ベースの医薬品は、カンナビノイドの治療特性を利用して、主に抗痙攣作用により、てんかんを含む様々な病状に対処します。例えば、2024年1月、アクメンティス・ヘルスケア・リミテッドは、特にレノックス・ガストー症候群、Dravet症候群、結節性硬化症複合体などの小児のてんかん発作を管理するために、インドの医薬品管理総局から承認された大麻植物由来の経口投与薬クラセピを発売しました。クラセピは、テトラヒドロカンナビノール（THC）の含有量を最小限に抑えており、特に従来の治療が無効であることが証明された場合に、発作の軽減に有効であることが示されています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界てんかん発作治療PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界のてんかん発作治療市場：成長率分析
• 世界のてんかん発作治療市場の実績：規模と成長, 2019-2024
• 世界のてんかん発作治療市場の予測：規模と成長, 2024-2029, 2034F
• 世界てんかん発作治療総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のてんかん発作治療市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 治療の実践
• 新興医薬品
• 個別療法
• 世界のてんかん発作治療市場発作の種類別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 部分発作
• 全身発作
• 分類不能な発作
• 世界のてんかん発作治療市場：投与経路別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 経口または頬粘膜
• 鼻腔
• 直腸
• 非経口
• 世界のてんかん発作治療市場：流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院薬局
• 小売薬局
• オンライン薬局
• 世界のてんかん発作治療市場、治療実践のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 抗てんかん薬（AED）
• 手術
• 迷走神経刺激（VNS）
• ケトジェニックダイエット
• 反応性神経刺激（RNS）
• 世界のてんかん発作治療市場、新薬の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 新しい抗てんかん薬
• カンナビジオールベースの薬物
• 遺伝子治療に基づく治療
• モノクローナル抗体
• 世界のてんかん発作治療市場、個別療法の種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 単剤療法
• 併用療法
• 補助療法

第7章 地域別・国別分析

• 世界のてんかん発作治療市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のてんかん発作治療市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• てんかん発作治療市場：競合情勢
• てんかん発作治療市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Johnson & Johnson Service Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • Novartis AG Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• GlaxoSmithKline plc.
• Takeda Pharmaceutical Co. Ltd.
• Medtronic plc
• GE HealthCare Technologies Inc.
• Teva Pharmaceutical Industries Ltd.
• Bausch Health Companies Inc.
• UCB S.A.
• Eisai Co. Ltd.
• Sumitomo Dainippon Pharma Co. Ltd.
• Dragerwerk AG & Co.KGaA
• H. Lundbeck A/S
• Apotex Inc.
• Masimo Corporation
• Fisher & Paykel Healthcare Limited
• Inspiration Healthcare Group Plc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• てんかん発作治療市場2029：新たな機会を提供する国
• てんかん発作治療市場2029：新たな機会を提供するセグメント
• てんかん発作治療市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Epileptic seizure treatment encompasses medical interventions and therapies aimed at managing and controlling seizures in individuals with epilepsy, a neurological disorder characterized by recurrent and unpredictable seizures. Treatment options may include medications, lifestyle modifications, dietary therapies, and other interventions tailored to each patient's specific needs, with the goal of reducing seizure frequency and severity and improving overall quality of life.

The main types of epileptic seizure treatment include established treatment practices, emerging drugs, and individualized therapies. Treatment practices involve methodologies used by healthcare professionals to manage symptoms, including pharmacological interventions, surgical procedures, and non-pharmacological therapies. These treatments address various seizure types, such as partial, generalized, and unclassified seizures, and can be administered via oral or buccal, nasal, rectal, or parenteral routes. Distribution channels include hospital pharmacies, retail pharmacies, and online pharmacies.

The epileptic seizures treatment market research report is one of a series of new reports from The Business Research Company that provides epileptic seizures treatment market statistics, including epileptic seizures treatment industry global market size, regional shares, competitors with an epileptic seizures treatment market share, detailed epileptic seizures treatment market segments, market trends and opportunities, and any further data you may need to thrive in the epileptic seizures treatment industry. This epileptic seizures treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The epileptic seizures treatment market size has grown strongly in recent years. It will grow from $3.42 billion in 2024 to $3.66 billion in 2025 at a compound annual growth rate (CAGR) of 6.9%. The growth in the historic period can be attributed to advancements in antiepileptic drugs (AEDs), research breakthroughs in epilepsy treatment, increased awareness and education, expanded access to healthcare, and a rise in the prevalence of epilepsy.

The epileptic seizures treatment market size is expected to see strong growth in the next few years. It will grow to $4.72 billion in 2029 at a compound annual growth rate (CAGR) of 6.6%. The growth in the forecast period can be attributed to precision medicine approaches, emerging therapeutic modalities, telemedicine and remote monitoring, healthcare integration and multidisciplinary care, and regulatory support and incentives. Major trends in the forecast period include personalized medicine, integration of digital health solutions, emerging therapeutic modalities, focus on comorbidities and quality of life, and regulatory support and market access.

The increasing incidence of epilepsy is anticipated to drive the growth of the market for treating epileptic seizures in the future. Epilepsy, a neurological disorder characterized by recurrent, unprovoked seizures, stems from abnormal electrical activity in the brain, leading to various symptoms such as convulsions, loss of consciousness, and sensory or behavioral disturbances. Factors contributing to the rising prevalence of epilepsy include improved survival rates among individuals with brain injuries or strokes and a growing elderly population. Effective treatment of epileptic seizures, primarily through antiepileptic drugs (AEDs), can significantly reduce their frequency and severity, thus ensuring patients' daily functioning and overall well-being. For instance, as of February 2024, the World Health Organization reported approximately 50 million people worldwide suffering from epilepsy, with about 5 million new diagnoses annually. Hence, the increasing incidence of epilepsy is fueling the expansion of the market for treating epileptic seizures.

Key players in the epileptic seizures treatment market are innovating to develop alternative treatment solutions, such as cannabis-based medications, particularly for patients unresponsive to traditional antiseizure drugs. Cannabis-based drugs, derived from the cannabis plant, harness the therapeutic properties of cannabinoids to address various medical conditions, including epilepsy, primarily for their anticonvulsant effects. For example, in January 2024, Akumentis Healthcare Ltd. introduced Clasepi, an orally administered cannabis plant-based medication approved by India's Drug Controller General to manage seizures, especially in children with conditions such as Lennox-Gastaut syndrome, Dravet syndrome, or Tuberous Sclerosis Complex. Clasepi, containing minimal tetrahydrocannabinol (THC) content, has shown efficacy in reducing seizures, particularly in cases where conventional treatments have proven ineffective, albeit it's cautioned for individuals allergic to cannabidiol or its constituents.

In March 2022, UCB SA bolstered its presence in the epileptic seizures treatment market by acquiring Zogenix Inc. for approximately $1.9 billion. This strategic move not only expands UCB's revenue potential but also grants access to promising epilepsy treatments, reinforcing its commitment to offering innovative solutions for severe forms of epilepsy such as Dravet syndrome. Zogenix Inc., a US-based biopharmaceutical company specializing in drugs and therapies for rare diseases, particularly rare pediatric epilepsy, thus enhances UCB's portfolio and strengthens its position in addressing the unmet medical needs of epilepsy patients.

Major companies operating in the epileptic seizures treatment market are Pfizer Inc., Johnson & Johnson Service Inc., Sanofi S.A., Abbott Laboratories, Novartis AG, GlaxoSmithKline plc., Takeda Pharmaceutical Co. Ltd., Medtronic plc, GE HealthCare Technologies Inc., Teva Pharmaceutical Industries Ltd., Bausch Health Companies Inc., UCB S.A., Eisai Co. Ltd., Sumitomo Dainippon Pharma Co. Ltd., Dragerwerk AG & Co.KGaA, H. Lundbeck A/S, Apotex Inc., Masimo Corporation, Fisher & Paykel Healthcare Limited, Inspiration Healthcare Group Plc., Phoenix Medical Systems (P) Ltd., Marinus Pharmaceuticals Inc., Alexza Pharmaceuticals Inc., Neurelis Inc., Veriton Pharma

North America was the largest region in the epileptic seizures treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the epileptic seizures treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the epileptic seizures treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The epileptic seizures treatment market consists of revenues earned by entities by providing services, such as medication management, rehabilitation services, diagnostic services, telemedicine, and remote monitoring services. The market value includes the value of related goods sold by the service provider or included within the service offering. The epileptic seizures treatment market also includes sales of anti-epileptic drugs, surgical implants, ketogenic diet products, seizure alarms, and vagus nerve stimulators which are used in providing the services. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Epileptic Seizures Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on epileptic seizures treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for epileptic seizures treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The epileptic seizures treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Treatment Practices; Emerging Drugs; Individual Therapies
• 2) By Seizure Type: Partial Seizures; Generalized Seizures; Unclassified Seizures
• 3) By Route of Administration: Oral Or Buccal; Nasal; Rectal; Parenteral
• 4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
• Subsegments:
• 1) By Treatment Practices: Antiepileptic Drugs (AEDs); Surgery; Vagus Nerve Stimulation (VNS); Ketogenic Diet; Responsive Neurostimulation (RNS)
• 2) By Emerging Drugs: New Antiepileptic Medications; Cannabidiol-based Drugs; Gene Therapy-Based Treatments; Monoclonal Antibodies
• 3) By Individual Therapies: Monotherapy; Combination Therapy; Adjunctive Therapy
• Companies Mentioned: Pfizer Inc.; Johnson & Johnson Service Inc.; Sanofi S.A.; Abbott Laboratories; Novartis AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Epileptic Seizures Treatment Market Characteristics

3. Epileptic Seizures Treatment Market Trends And Strategies

4. Epileptic Seizures Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Epileptic Seizures Treatment Growth Analysis And Strategic Analysis Framework

• 5.1. Global Epileptic Seizures Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Epileptic Seizures Treatment Market Growth Rate Analysis
• 5.4. Global Epileptic Seizures Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Epileptic Seizures Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Epileptic Seizures Treatment Total Addressable Market (TAM)

6. Epileptic Seizures Treatment Market Segmentation

• 6.1. Global Epileptic Seizures Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Treatment Practices
• Emerging Drugs
• Individual Therapies
• 6.2. Global Epileptic Seizures Treatment Market, Segmentation By Seizure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Partial Seizures
• Generalized Seizures
• Unclassified Seizures
• 6.3. Global Epileptic Seizures Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral Or Buccal
• Nasal
• Rectal
• Parenteral
• 6.4. Global Epileptic Seizures Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• 6.5. Global Epileptic Seizures Treatment Market, Sub-Segmentation Of Treatment Practices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Antiepileptic Drugs (AEDs)
• Surgery
• Vagus Nerve Stimulation (VNS)
• Ketogenic Diet
• Responsive Neurostimulation (RNS)
• 6.6. Global Epileptic Seizures Treatment Market, Sub-Segmentation Of Emerging Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• New Antiepileptic Medications
• Cannabidiol-based Drugs
• Gene Therapy-Based Treatments
• Monoclonal Antibodies
• 6.7. Global Epileptic Seizures Treatment Market, Sub-Segmentation Of Individual Therapies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Monotherapy
• Combination Therapy
• Adjunctive Therapy

7. Epileptic Seizures Treatment Market Regional And Country Analysis

• 7.1. Global Epileptic Seizures Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Epileptic Seizures Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Epileptic Seizures Treatment Market

• 8.1. Asia-Pacific Epileptic Seizures Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Epileptic Seizures Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Epileptic Seizures Treatment Market, Segmentation By Seizure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Epileptic Seizures Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Epileptic Seizures Treatment Market

• 9.1. China Epileptic Seizures Treatment Market Overview
• 9.2. China Epileptic Seizures Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Epileptic Seizures Treatment Market, Segmentation By Seizure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Epileptic Seizures Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Epileptic Seizures Treatment Market

• 10.1. India Epileptic Seizures Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Epileptic Seizures Treatment Market, Segmentation By Seizure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Epileptic Seizures Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Epileptic Seizures Treatment Market

• 11.1. Japan Epileptic Seizures Treatment Market Overview
• 11.2. Japan Epileptic Seizures Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Epileptic Seizures Treatment Market, Segmentation By Seizure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Epileptic Seizures Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Epileptic Seizures Treatment Market

• 12.1. Australia Epileptic Seizures Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Epileptic Seizures Treatment Market, Segmentation By Seizure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Epileptic Seizures Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Epileptic Seizures Treatment Market

• 13.1. Indonesia Epileptic Seizures Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Epileptic Seizures Treatment Market, Segmentation By Seizure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Epileptic Seizures Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Epileptic Seizures Treatment Market

• 14.1. South Korea Epileptic Seizures Treatment Market Overview
• 14.2. South Korea Epileptic Seizures Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Epileptic Seizures Treatment Market, Segmentation By Seizure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Epileptic Seizures Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Epileptic Seizures Treatment Market

• 15.1. Western Europe Epileptic Seizures Treatment Market Overview
• 15.2. Western Europe Epileptic Seizures Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Epileptic Seizures Treatment Market, Segmentation By Seizure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Epileptic Seizures Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Epileptic Seizures Treatment Market

• 16.1. UK Epileptic Seizures Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Epileptic Seizures Treatment Market, Segmentation By Seizure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Epileptic Seizures Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Epileptic Seizures Treatment Market

• 17.1. Germany Epileptic Seizures Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Epileptic Seizures Treatment Market, Segmentation By Seizure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Epileptic Seizures Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Epileptic Seizures Treatment Market

• 18.1. France Epileptic Seizures Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Epileptic Seizures Treatment Market, Segmentation By Seizure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Epileptic Seizures Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Epileptic Seizures Treatment Market

• 19.1. Italy Epileptic Seizures Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Epileptic Seizures Treatment Market, Segmentation By Seizure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Epileptic Seizures Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Epileptic Seizures Treatment Market

• 20.1. Spain Epileptic Seizures Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Epileptic Seizures Treatment Market, Segmentation By Seizure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Epileptic Seizures Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Epileptic Seizures Treatment Market

• 21.1. Eastern Europe Epileptic Seizures Treatment Market Overview
• 21.2. Eastern Europe Epileptic Seizures Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Epileptic Seizures Treatment Market, Segmentation By Seizure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Epileptic Seizures Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Epileptic Seizures Treatment Market

• 22.1. Russia Epileptic Seizures Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Epileptic Seizures Treatment Market, Segmentation By Seizure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Epileptic Seizures Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Epileptic Seizures Treatment Market

• 23.1. North America Epileptic Seizures Treatment Market Overview
• 23.2. North America Epileptic Seizures Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Epileptic Seizures Treatment Market, Segmentation By Seizure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Epileptic Seizures Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Epileptic Seizures Treatment Market

• 24.1. USA Epileptic Seizures Treatment Market Overview
• 24.2. USA Epileptic Seizures Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Epileptic Seizures Treatment Market, Segmentation By Seizure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Epileptic Seizures Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Epileptic Seizures Treatment Market

• 25.1. Canada Epileptic Seizures Treatment Market Overview
• 25.2. Canada Epileptic Seizures Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Epileptic Seizures Treatment Market, Segmentation By Seizure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Epileptic Seizures Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Epileptic Seizures Treatment Market

• 26.1. South America Epileptic Seizures Treatment Market Overview
• 26.2. South America Epileptic Seizures Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Epileptic Seizures Treatment Market, Segmentation By Seizure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Epileptic Seizures Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Epileptic Seizures Treatment Market

• 27.1. Brazil Epileptic Seizures Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Epileptic Seizures Treatment Market, Segmentation By Seizure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Epileptic Seizures Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Epileptic Seizures Treatment Market

• 28.1. Middle East Epileptic Seizures Treatment Market Overview
• 28.2. Middle East Epileptic Seizures Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Epileptic Seizures Treatment Market, Segmentation By Seizure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Epileptic Seizures Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Epileptic Seizures Treatment Market

• 29.1. Africa Epileptic Seizures Treatment Market Overview
• 29.2. Africa Epileptic Seizures Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Epileptic Seizures Treatment Market, Segmentation By Seizure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Epileptic Seizures Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Epileptic Seizures Treatment Market Competitive Landscape And Company Profiles

• 30.1. Epileptic Seizures Treatment Market Competitive Landscape
• 30.2. Epileptic Seizures Treatment Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Johnson & Johnson Service Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

31. Epileptic Seizures Treatment Market Other Major And Innovative Companies

• 31.1. GlaxoSmithKline plc.
• 31.2. Takeda Pharmaceutical Co. Ltd.
• 31.3. Medtronic plc
• 31.4. GE HealthCare Technologies Inc.
• 31.5. Teva Pharmaceutical Industries Ltd.
• 31.6. Bausch Health Companies Inc.
• 31.7. UCB S.A.
• 31.8. Eisai Co. Ltd.
• 31.9. Sumitomo Dainippon Pharma Co. Ltd.
• 31.10. Dragerwerk AG & Co.KGaA
• 31.11. H. Lundbeck A/S
• 31.12. Apotex Inc.
• 31.13. Masimo Corporation
• 31.14. Fisher & Paykel Healthcare Limited
• 31.15. Inspiration Healthcare Group Plc.

32. Global Epileptic Seizures Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Epileptic Seizures Treatment Market

34. Recent Developments In The Epileptic Seizures Treatment Market

35. Epileptic Seizures Treatment Market High Potential Countries, Segments and Strategies

• 35.1 Epileptic Seizures Treatment Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Epileptic Seizures Treatment Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Epileptic Seizures Treatment Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer